Marsi Bionics
Vaciamadrid
About Marsi Bionics
Marsi-Bionics designs, manufactures and sells modular robotic orthoses for clinical rehabilitation and movility assistance. Its modular technology, ARES, enables self-adaptive gait exoskeletons, ranging from single joint active orthoses (hip, knee), to full Trunk-Hip-Knee-Ankle-Foot active orthoses, customizable to the physiology and requirements of each user or patient. The company's products includes, MAK an active knee orthosis (CE Marking April 2020), ATLAS, the first paediatric exoskeleton (CE Marking in first half of 2021) and the exoskeleton for adults STELO.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Last round: Series Unknown (Jun 2023)
- Website: marsibionics.com
- Phone: +34911898293
Industries & Categories
Health Care, Information Technology, Manufacturing, Rehabilitation, Robotics
Social Profiles
Canonical: https://fsome.com/organization/marsi-bionics-23135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.